Cancer-associated proteins can modulate lipid metabolism by activating crucial enzymes such as fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC), which are vital for de novo lipogenesis, promoting lipid accumulation and supplying energy for tumor growth (You et al., 2023). The gene discussed is FASN; the disease is neoplasm.